West Schart Conte Bastianelli is categorized under Doctors in Roselle Park, NJ and active since 2005.
West Schart Conte Bastianelli was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Gerald West at the company’s single location by writing to 505 Chestnut St # 2, Roselle Park, New Jersey NJ 07204 or by phoning (908) 241-0200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | West Schart Conte Bastianelli |
| Contact Person: | Gerald West |
| Address: | 505 Chestnut St # 2, Roselle Park, New Jersey 07204 |
| Phone Number: | (908) 241-0200 |
| Website Address: | njentfacialplastics.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
West Schart Conte Bastianelli was started in 2005 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gerald West for inquiries that concern West Schart Conte Bastianelli by calling the company number (908) 241-0200, as your correspondence is most welcome. Additionally, the physical location of the single location of West Schart Conte Bastianelli can be found at the coordinates 40.66675,-74.264965 as well as the street address 505 Chestnut St # 2 in Roselle Park, New Jersey 07204.
For its online presence, you may visit West Schart Conte Bastianelli’s website at njentfacialplastics.com and engage with its social media outlets through on Twitter and on Facebook.